248
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Late Effects of Multiagent Chemotherapy on Salivary Secretion in Children Cancer Survivors

, DMD, , DMD, , DMD, , DMD, PhD, , DMD, MSc, PhD & , MD, MSc, PhD
Pages 186-191 | Received 26 Jun 2013, Accepted 12 Aug 2013, Published online: 16 May 2014

REFERENCES

  • Rie LAG, Eisner MP, Kosary CLFAEdwards BK, Hankey BFAEdwards BK, Miller BAEdwards BK, Clegg LEdwards BK, Mariotto A, Feuer EJEdwards BK,, “SEER Cancer Statistics Review, 1975–2002.” Bethesda, MD: National Cancer Institute, 2005. Accessed at: http://seer.cancer.gov/csr/1975_2002/
  • Hewitt M, Weiner SL, Simone JV: “Childhood Cancer Survivorship: Improving Care and Quality of Life.” Washington, DC: National Academies Press, 2003.
  • Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL: Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Eng J Med 355:1572–1582, 2006.
  • Wogelius P, Rosthøj S, Dahllöf G, Poulsen S: Oral health-related quality of life among survivors of childhood cancer. Int J Paediatr Dent 21:465–467, 2011.
  • Najafi Sh, Tohidastakrad Z, Momenbeitollahi J: The long-term effects of chemo radiotherapy on oral health and dental development in childhood cancer. J Dent (Tehran) 8:39–43, 2011.
  • Hsieh SG, Hibbert S, Shaw P, Ahern V, Arora M: Association of cyclophosphamide use with dental developmental defects and salivary gland dysfunction in recipients of childhood antineoplastic therapy. Cancer 117:2219–2227, 2011.
  • Alpaslan G, Alpaslan C, Gogen H, Oguz A, Iner S, Karaden Iz C: Disturbances in oral and dental structures in patients with pediatric lymphoma after chemotherapy. A preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87:317–321, 1999.
  • Holtta P, Alaluusua S, Saarinen-Pihkala UM, Peltola J, Hovi L: Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children. Cancer 103:181–190, 2005.
  • Kaste SC, Goodman P, Leisenring W, Stovall M, Hayashi RJ, Yeazel M, Beiraghi S, Hudson MM, Sklar CA, Robison LL, Baker KS: Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood Cancer Survivor Study. Cancer 115:5817–5827, 2009.
  • Dahllöf G, Bågesund M, Remberger M, Ringdén O: Risk factors for salivary dysfunction in children one year after allogeneic bone marrow transplantation. Eur J Cancer Oral Oncol 33:327–331, 1997.
  • Dens F, Boogaerts M, Boute P, Declerck D, Demuynck H, Vinckier F: Caries-related salivary microorganisms and salivary flow rate in bone marrow recipients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:38–43, 1996.
  • Singh N, Scully C, Joyston S: Oral complications of cancer therapies: prevention and management. Clin Oncol 8:15–24, 1996.
  • Peterson DE, Sonis ST: Oral complications of cancer chemotherapy: present status and future studies. Cancer Treat Rep 66:1251–1256, 1982.
  • WHO: “Oral Health Surveys—Basic Methods.” 4th ed. Geneva, Switzerland: World Health Organization; 1997.
  • Sreebny LM: Saliva in health and disease: an appraisal and update. Int Dent J 50:140–161, 2000.
  • Sreebny LM: Saliva–salivary gland hypofunction (SGH). FDI Working Group 10. J Dent Assoc S Afr 47:498–501, 1992.
  • Márton K, Boros I, Arga G, Zelles T, Fejérdy P, Zeher M, Nagy G: Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjögren's syndrome. Oral Dis 12:480–486, 2006.
  • Kitasako Y, Burrow FB, Huq NL, Stacey MA, Reynolds EC, Tagami J: A simplified quantitative test-adapted Checkbuf test for resting saliva buffering capacity compared with a standard test. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108:551–556, 2009.
  • Ribelles Llop M, Guinot Jimeno F, Mayne Acien R, Bellet Dalmau LJ: Effects of xylitol chewing gum on salivary flow rate, pH, buffering capacity and presence of Streptococcus mutans in saliva. Eur J Paediatr Dent 11:9–14, 2010.
  • Tylavsky F, Smith K, Surprise H, Garland S, Yan X, McCammon E, Hudson M, Pui ChP, Kaste S: Nutritional intake of long-term survivors of childhood acute lymphoblastic leukemia: evidence for bone health interventional opportunities. Pediatr Blood Cancer 55:1326–1369, 2010.
  • Rivadeneira DE, Evoy D, Fahey TJ III, Lieberman MD,M Daly JM: Nutritional support of the cancer patient. CA Cancer J Clin 48:69–80, 1998.
  • Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, Yeazel M, Recklitis CJ, Marina N, Robison LR, Oeffinger KC, and the Childhood Cancer Survivor Study Investigators: Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA 290:1583–1592, 2003.
  • Hobdell M, Petersen PE, Clarkson J, Johnson N: Global goals for oral health 2020. Int Dent J. 53:285–288, 2003.
  • Avsar A, Elli M, Darka O, Pinarli G: Long-term effects of chemotherapy on caries formation, dental development, and salivary factors in childhood cancer survivors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:781–789, 2007.
  • Oguz A, Cetiner S, Karadeniz C, Alpaslan G, Alplaslan C, Pinarli G: Long-term effects of chemotherpy on orodental structures in children with non-Hodgkin's lymphoma. Eur J Oral Sci 112:8–11, 2004.
  • Marec-Berard P, Azzi D, Chaux-Bodard AG, Lagrange H, Gourmet R, Bergeron C: Long-term effects of chemotherapy on dental status in children treated for nephroblastoma. Pediatr Hematol Oncol 22:581–588, 2005.
  • Bruno-Ambrosius K, Yucel-Lindberg T, Twetman S: Salivary buffer capacity in relation to menarche and progesterone levels in saliva from adolescent girls: a longitudinal study. Acta Odon Scan 62:269–272, 2004.
  • Moritsuka M, Kitasako Y, Burrow MF, Ikeda M, Tagami J, Nomura S: Quantitative assessment for stimulated saliva flow rate and buffering capacity in relation to different ages. J Dent 34:716–720, 2006.
  • Tenovuo J: Salivary parameters of relevance for assessing caries activity in individuals and populations. Community Dentistry and Oral Epidemiol 25:82–86, 1997.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.